Diabetes Care APC and Open Access: ADA Pricing Logic, Page-Charge Tradeoffs, and When Gold OA Is Worth It
Diabetes Care APC is charged per typeset page ($175 or $250; ADA sources differ), plus a per-page Open Choice fee. Strong clinical-diabetes reach either way.
Readiness scan
APC budgeted? See what Diabetes Care reviewers are likely to push back on.
The fee is one decision. Getting through review is the harder one. Run the Free Readiness Scan with Diabetes Care as your target to see desk-rejection risk, likely reviewer concerns, and journal fit.
Diabetes Care publishing costs and open access options
APC is one cost. Funder mandates, institutional agreements, and access route timing all shape what you actually pay.
What shapes what you pay
- Diabetes Care offers open access publishing. Check whether your institution has a read-and-publish agreement.
- Funder mandates (NIH, Wellcome, UKRI) may require immediate OA, verify compliance before choosing a subscription route.
- Check the journal's correspondence for any access-route deadline; an APC does not establish when that choice is due.
When OA is worth the cost
- When your funder or institution requires it, non-compliance can affect future funding.
- When your topic benefits from broad immediate access beyond institutional subscribers.
- Open access can widen practical access, but it does not change whether the journal fits the manuscript.
Quick answer: Diabetes Care bills article-processing charges per typeset journal page, and Open Choice (immediate open access) adds a further per-page charge. The journal remains hybrid, so authors can leave the Open Choice option off. The Instructions for Authors list $250 per page, plus $175 per page for Open Choice, for articles submitted on or after February 1, 2024 (read 2026-10-09); ADA's journal-policies page lists the two figures the other way round, so the publisher's documents differ.
The practical catch is the same one many authors miss at other society journals: the standard route already carries a per-page article-processing charge, so the useful comparison is the standard per-page bill against the Open Choice total, not APC versus free. For the hub, see the Diabetes Care journal page.
Diabetes Care APC at a glance
Item | Current position |
|---|---|
Journal model | Hybrid |
Open Choice charge (read 2026-10-09) | Additional per-page charge: $175 in the Instructions for Authors, $250 in ADA's journal policies |
Standard charge on non-invited articles (read 2026-10-09) | Per typeset journal page: $250 in the Instructions for Authors, $175 in ADA's journal policies |
Discounts and waivers | Request through ADA's Publication Fee Request form |
2024 impact factor | 22.6 |
5-year JIF | 16.7 |
Category rank | 6 / 191 |
Total cites | 77,907 |
The real first decision is rarely the fee itself. It is whether the paper genuinely belongs in Diabetes Care's clinical diabetes lane. A quick Diabetes Care submission readiness check usually tells you more than the APC discussion alone.
If the cost looks workable, the harder question is whether your paper will clear desk review. A Diabetes Care desk-rejection risk check takes about 2 to 3 minutes before you commit to these fees.
What the ADA pricing logic means in practice
The public Diabetes Care author materials describe this practical structure:
- a hybrid publication model
- a per-typeset-page article-processing charge on non-invited articles
- an additional per-page charge for Open Choice
That makes Diabetes Care one of those journals where authors should think in deltas, not headlines.
Route | Practical cost logic |
|---|---|
Open Choice | Standard per-page charge plus the additional Open Choice per-page charge |
Standard route | Per-page article-processing charge on non-invited articles, no Open Choice charge |
So when authors compare routes, the real question is usually:
- how large is the page-charge bill on the subscription route?
- how much additional spend buys immediate OA?
That is a more honest planning model than pretending the subscription route is always zero.
Metrics context behind the APC
Metric | Current figure | Why it matters |
|---|---|---|
JIF | 22.6 | Strong flagship position in clinical diabetes |
5-year JIF | 16.7 | Sustained citation performance, not just one-year noise |
SJR | 6.566 | Prestige-weighted influence remains high in clinical diabetes |
Category rank | 6 / 191 | Top-tier endocrinology and metabolism standing |
Total cites | 77,907 | Broad clinical and policy visibility |
This is why Diabetes Care can justify a moderate society-journal APC. It is not just another diabetes journal. It is one of the main journals shaping the evidence environment around diabetes management, prevention, and ADA care standards.
Long-run citation context
Year | JIF |
|---|---|
2017 | 13.4 |
2018 | 15.3 |
2019 | 16.0 |
2020 | 16.0 |
2021 | 19.1 |
2022 | 16.2 |
2023 | 14.8 |
2024 | 16.6 |
The year-over-year move is positive. Diabetes Care is up from 14.8 in 2023 to 16.6 in 2024. That bounce matters because it shows the journal still carries strong current attention in clinical diabetes despite more crowded competition from broader endocrinology and metabolism venues.
Why the route choice matters here
Scenario | What usually makes sense |
|---|---|
Strong clinical-care paper with funded OA support | Gold OA is easy to justify |
NIH or similar funding but no need for immediate final-version OA | Subscription route may be enough |
Page-charge bill is already meaningful | OA premium may be smaller than it looks |
Personal payment with no clear visibility advantage | Subscription route is usually more rational |
The reason this journal is different from many pure-APC pages is simple: Diabetes Care already has unusually strong readership inside clinical diabetes even without immediate gold OA.
Why the ADA route question is more about audience than compliance
For a lot of journals, the APC choice is mainly about meeting a funder rule. At Diabetes Care, the route choice is often more about how much extra value immediate OA really adds on top of an already powerful clinical readership base.
Diabetes Care already benefits from:
- strong institutional access across medicine
- ADA brand visibility
- routine readership from clinicians, guideline-aware researchers, and diabetes policy teams
That means the subscription route is not the same thing as invisibility. Authors sometimes overestimate what the APC is buying them because they picture a niche journal hidden behind a paywall. Diabetes Care is not that kind of venue.
The real question is narrower:
- does the paper need the final version open immediately for funder, policy, or public-health reasons?
- or is the journal's existing clinical reach already enough?
That distinction matters because many authors are not deciding between "widely read" and "not read." They are deciding between "widely read through existing clinical channels" and "widely read plus immediate final-version openness."
Readiness check
Run the scan while the topic is in front of you.
See score, top issues, and journal-fit signals before you submit.
Where the APC is easiest to justify
The OA premium is easiest to defend when the paper has a direct practice-facing or policy-facing audience:
- trials or cohort analyses likely to be cited in care pathways
- implementation studies where health-system teams need immediate access
- papers backed by funders or institutions that already support the ADA route
It is harder to justify when:
- the manuscript is clinically adjacent but not actually care-changing
- the audience already sits inside institutions with routine access
- the authors are paying personally because they assume all high-end medical papers must be gold OA
For Diabetes Care, the strongest planning move is to decide first whether the article deserves the journal's audience. Once that answer is yes, the APC decision becomes a more ordinary budget and dissemination question.
What we see in pre-submission review work on Diabetes Care papers
In our pre-submission review work, the most common mistake is not underbudgeting the APC. It is misunderstanding the editorial center.
What usually works:
- studies that clearly change diabetes care decisions
- clinically interpretable endpoints
- work that would matter to ADA guideline readers, not just to metabolic specialists
What usually creates regret:
- mechanistic metabolism papers dressed up as diabetes-care manuscripts
- statistically tidy studies with weak practice consequence
- authors focusing on the billing model before deciding whether the paper is really a Diabetes Care paper
That is why the APC decision should follow the fit decision.
Submit if / Think twice if
Submit and consider paying for OA if:
- the manuscript has real diabetes-care consequence
- the institution or grant covers most of the fee
- immediate final-version access strengthens the paper's clinical reach
- the page-charge comparison makes the OA premium reasonable
Think twice if:
- the work is more basic or mechanistic than clinical
- the subscription route already reaches the actual audience well
- you have not budgeted the page-charge alternative honestly
- you would be paying personally without a strong reason
Practical verdict
For Diabetes Care APC, the most useful answer is:
- Open Choice: the standard per-page charge plus an additional per-page charge
- standard route: the per-page article-processing charge on non-invited articles
- real decision: compare the Open Choice premium against the standard per-page bill, not against imaginary zero
That is the planning frame most authors actually need.
Frequently asked questions
Diabetes Care bills article-processing charges per typeset journal page on non-invited articles, and the Open Choice option, which makes the article free to read on publication, adds a further per-page charge. The Instructions for Authors list $250 per page, plus $175 per page for Open Choice, for articles submitted on or after February 1, 2024 (read 2026-10-09); ADA's journal-policies page lists the two figures the other way round, so the publisher's documents differ. Check the current figures before you submit.
Only for invited articles or with a waiver. ADA assesses article-processing charges on non-invited articles whether or not the author chooses Open Choice, and authors who cannot meet them can request a discount or waiver through ADA's Publication Fee Request form; ADA says waiver status does not influence the editorial decision.
Because ADA's base charge is a per-typeset-page article-processing charge on non-invited articles, and Open Choice adds a further per-page charge. Authors comparing routes need to weigh the standard per-page bill against the Open Choice total rather than against zero.
Yes. Diabetes Care has one of the strongest readership positions in clinical diabetes, helped by the ADA ecosystem, the Standards of Care franchise, and broad institutional access in medicine.
It is easiest to justify when the article has clear clinical-care consequence, the institution or grant covers most of the fee, and immediate final-version access matters more than the journal's already strong readership on the subscription route.
Sources
Free guide
The list price is rarely the price you pay.
Waivers, funder agreements and institutional deals move it, and the deadline for most of them is submission, after which there is no appeal. Every figure in the guide was read off the publisher or funder page that sets it, on the date shown, and each one is linked at the end.
Before you upload
Want the full picture on Diabetes Care?
Scope, selectivity, what editors want, common rejection reasons, and submission context, all in one place.
These pages attract evaluation intent more than upload-ready intent.
Private API processing. Your manuscript is not used to train models.
Put the guidance to work
Build a journal decision from more than one signal.
Use comparison data as a starting point, then confirm the live source that governs the actual submission decision.
Where to go next
Start here
Same journal, next question
- Diabetes Care Submission Guide: Process, Timeline & Editor Tips
- Is Diabetes Care a Good Journal? A Practical Fit Verdict
- Diabetes Care Impact Factor 2026: Ranking, Quartile & What It Means
- Diabetes Care Acceptance Rate: What Authors Can Use
- How to Avoid Desk Rejection at Diabetes Care
- Diabetes Care (ADA) 'Under Review': What Each Status Means